United Laboratories International Holdings (FRA:UNJ) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UNJ United Laboratories International Holdings Ltd FRA:UNJ
67 GF Score
Price €0.87
GF Value €0.95
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings 3-Month Share Buyback Ratio?

United Laboratories International Holdings FRA:UNJ -0.57% 67 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates FRA:UNJ with a GF Score™ of 67/100 and a GF Value™ of €0.95 (Fairly Valued). The stock has 5 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

FRA:UNJ
67GF Score
United Laboratories International Holdings Ltd FRA:UNJ
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
United Laboratories International Holdings (FRA:UNJ) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for United Laboratories International Holdings and its competitors.
Is United Laboratories International Holdings' 3-Month Share Buyback Ratio too high?
United Laboratories International Holdings' current 3-Month Share Buyback Ratio is 0.00. Overall, United Laboratories International Holdings has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' 3-Month Share Buyback Ratio compare to ZTS?
United Laboratories International Holdings' 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Month Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for United Laboratories International Holdings and its competitors. United Laboratories International Holdings's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (FRA:UNJ) is currently considered Fairly Valued. The stock's GF Value™ is €0.95, compared to a current price of €0.87 — trading 8.4% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. United Laboratories International Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be undervalued. The current stock price of €0.87 is trading 8.4% below its estimated GF Value™ of €0.95. GuruFocus considers United Laboratories International Holdings to be Fairly Valued.

Key valuation signals for FRA:UNJ:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: €0.95 vs. price of €0.87 (8.4% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Laboratories International Holdings Business Description

Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
67GF Score

Get the complete analysis for FRA:UNJ

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.87
Price
€0.95
GF Value